İdil Çetin and M. Topçul, “Antiproliferative Effects of EGFR inhibitor Cetuximab and PARP Inhibitor Combination on Non-Small Cell Lung Cancer Cell Line A549 and Cervical Cancer Cell Line HeLa : Effects of Combination of EGFR inhibitor Cetuximab and PARP inhibitor”, Cell Mol Biol (Noisy-le-grand), vol. 68, no. 8, pp. 47–51, Aug. 2022.